The FDA gives the green light to the first gene therapy for deafness
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical milestone. • 4m Listen
All Things Considered is a vital daily companion to people who strive to stay informed and in touch. Through the incisive and intuitive, relevant and reflective reporting that characterizes the program, All Things Considered transforms the way listeners understand current events and view the world. Andrea Seabrook hosts a one-hour edition of the program on Saturday and Sunday.